Comments
Johnson & Johnson diabetes drug tops older therapies in studies
10.06.2012. | (Reuters) - An experimental treatment for type 2 diabetes developed by Johnson & Johnson demonstrated greater reduction in blood sugar than Merck & Co's Januvia and an older common treatment, glimepiride, according to data from a pair of late stage clinical trials....
